Leave message
Can’t find what you’re looking for?
Fill out this form to inquire about our custom protein services!
Inquire about our Custom Services >>
| Cat. No. | Species | Product Description | Structure | Purity | Feature |
|---|---|---|---|---|---|
| GA3-H82E3 | Human | Biotinylated Human Galectin-3 Protein, His,Avitag™ |  |
|
|
| GA3-H5247 | Human | Human Galectin-3 Protein, His Tag |  |
|
|
| GA3-H5129 | Human | Human Galectin-3 Protein, His Tag (MALS verified) |  |
|
The purity of Human Galectin-3, His Tag (Cat. No. GA3-H5129) is more than 90% and the molecular weight of this protein is around 23-35 kDa verified by SEC-MALS.
| Name | Research Code | Research Phase | Company | First Brand Name | First Approved Country | First Indication | First Approved Company | First Approved Date | Indications | Clinical Trials |
|---|---|---|---|---|---|---|---|---|---|---|
| Ocriplasmin | A-01016; THR-409 | Approved | Thrombogenics | Jetrea, Jejetrea | United States | Vitreomacular Adhesion | Thrombogenics Inc | 2012-10-17 | Vitreous Detachment; Arterial Occlusive Diseases; Disease Progression; Stroke; Retinal Diseases; Diabetic macular oedema; Uveitis; Vitreomacular Adhesion; Eye Diseases; Venous Thrombosis; Macular Degeneration; Diabetic Retinopathy; Retinal Vein Occlusion | Details |
| Name | Research Code | Research Phase | Company | Indications | Clinical Trials |
|---|---|---|---|---|---|
| Belapectin | GR-MD-02 | Phase 3 Clinical | Galectin Therapeutics Inc | Squamous Cell Carcinoma of Head and Neck; Metabolic Dysfunction-Associated Steatotic Liver Disease; Liver Cirrhosis; Hypertension, Portal; Psoriasis; Hepatic Insufficiency; Esophageal and Gastric Varices; Melanoma; Carcinoma, Non-Small-Cell Lung | Details |
| Olitigaltin | GB-0139; TD-139 | Phase 2 Clinical | The University Of Edinburgh, Lund University Foundation | Idiopathic Pulmonary Fibrosis; Coronavirus Disease 2019 (COVID-19) | Details |
| Galactomannan C | GM-CT-01 | Phase 2 Clinical | Galectin Therapeutics Inc | Head and Neck Neoplasms; Coronavirus Disease 2019 (COVID-19); Breast Neoplasms; Prostatic Neoplasms; Colorectal Neoplasms; Bile Duct Neoplasms; Lung Neoplasms; Gallbladder Neoplasms; Melanoma | Details |
| Selvigaltin | GB-1211; GB1211 | Phase 2 Clinical | Galecto Inc | Squamous Cell Carcinoma of Head and Neck; Metabolic Dysfunction-Associated Steatotic Liver Disease; Hepatic Insufficiency; Melanoma; Carcinoma, Non-Small-Cell Lung | Details |
| ProLectin-M | Phase 2 Clinical | BioXyTran Inc | Cytokine Release Syndrome; Coronavirus Disease 2019 (COVID-19); Influenza, Human | Details | |
| Gal-400 | Gal-400 | Phase 1 Clinical | Galecto Inc | Metabolic Dysfunction-Associated Steatotic Liver Disease; Liver Cirrhosis | Details |
This web search service is supported by Google Inc.
A-Z
